Why SkinHealth Systems Inc. (SKIN) International Revenue Trends Deserve Your Attention
Explore how SkinHealth Systems Inc.'s (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Beauty Health Q1 Earnings Call Highlights
Beauty Health NASDAQ: SKIN, referred to by executives as SkinHealth Systems following a recent rebrand, reported first-quarter 2026 net sales of $64.9 million, down 6.7% from the prior year, as weaker device placements continued to weigh on growth. The company said adjusted EBITDA rose 17% year over year to $8.5 million, exceeding the high end of its guidance range.
SkinHealth Systems Inc. (SKIN) Q1 2026 Earnings Call Transcript
SkinHealth Systems Inc. (SKIN) Q1 2026 Earnings Call Transcript
SkinHealth Systems Inc. (SKIN) Reports Q1 Loss, Lags Revenue Estimates
SkinHealth Systems Inc. (SKIN) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.08 per share a year ago.
Compared to Estimates, SkinHealth Systems Inc. (SKIN) Q1 Earnings: A Look at Key Metrics
The headline numbers for SkinHealth Systems Inc. (SKIN) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
SkinHealth Systems Inc. (SKIN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
SkinHealth Systems Inc. (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Beauty Health Company (SKIN) Q4 2025 Earnings Call Transcript
The Beauty Health Company (SKIN) Q4 2025 Earnings Call Transcript
Beauty Health (SKIN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Beauty Health (SKIN) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The Beauty Health Company (SKIN) Reports Q4 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.08 per share a year ago.
Unveiling Beauty Health (SKIN) Q4 Outlook: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Beauty Health (SKIN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Unlocking Beauty Health (SKIN) International Revenues: Trends, Surprises, and Prospects
Explore how Beauty Health's (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Here's What Key Metrics Tell Us About Beauty Health (SKIN) Q3 Earnings
Although the revenue and EPS for Beauty Health (SKIN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
